I

IM Cannabis Corp.

IMCC Nasdaq Healthcare · Medicinal Chemicals & Botanical Products Central District, Israel www.imcannabis.com
$4.19
Mkt Cap 24.7M
Important Events in the Development of the Business from January 1, 2025, to the date of this Annual Report . Significant sales of our listed securities could depress the market price of our securitie…

Important Events in the Development of the Business from January 1, 2025, to the date of this Annual Report . Significant sales of our listed securities could depress the market price of our securities and impair our ability to raise capital. Sales of a substantial number of Common Shares or other equity-related securities in the public markets by us or by our shareholders could depress the market price of our securities and impair our ability to raise capital through the sale of additional equity securities. We cannot predict the effect that future sales of Common Shares or other equity-related securities would have on the market price of the Common Shares. The price of the Common Shares could be affected by possible sales of the Common Shares by hedging or arbitrage trading activity. We may issue additional securities in the future, which may dilute our shareholder’s holdings. We have issued a significant number of Common Shares and we may do so in the future. Common Shares to be issued in future equity offerings could cause the market price of our Common Shares to decline and could have an adverse effect on our earnings per share if and when we become profitable. In addition, future sales of our Common Shares or other securities in the public markets, or the perception that these sales may occur, could cause the market price of our Common Shares to decline, and could materially impair our ability to raise capital through the sale of additional securities.

/100 Overall
Calculating score…
Running full analysis
📊 Key Metrics
Loading full analysis…
REVENUE TTM
$38.2M
FCF TTM
$3.1M
P/FCF
8.0x
Running full 6-factor analysis…